PHA3042 Modern drug development
Faculty of Science
PHA3042 Modern drug development is a level 3, 6-credit-point, undergraduate unit from the Faculty of Science, offered in 2020 in Semester 2 at Clayton. It has no prerequisites and unlocks 1 unit.
- Credit points
- 6
- Offered in 2020
- Semester 2
- Clayton
- Assessment
- Exam 25%
- and 1 other task
This is the 2020 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review PHA3042.
Requisites
Before PHA3042
No prerequisites or corequisites besides the enrolment rules below.
After PHA3042
1 unit list PHA3042 as a prerequisite or corequisite.
Overview
Modern drug development will provide you with an appreciation of the process of discovery, testing, approval and marketing of new drugs. This will include the diseases most likely to be targeted by pharmaceutical companies for drug development; the technical issues underlying drug discovery; the role of genomics in identifying novel targets; rational drug design; the importance of screens including molecular models and high throughput screening; disease models; case studies illustrating the successful development of drugs. Career opportunities in all aspects of drug development will be highlighted.
Offerings in 2020
| Teaching period | Campus | Mode |
|---|---|---|
| Second semester | Clayton | On campus |
Assessment
- In-semester assessmentThreshold hurdle75%
- Examination (1 hour and 40 minutes)Threshold hurdle25%
Learning outcomes
When you finish this unit, you should be able to:
- 1
Discuss the steps involved in the drug discovery process, including sources of drugs, how targets are identified and screening processes that can be used to test for desired activity;
- 2
Discuss the steps involved in developing a commercial product from a potential drug candidate, including the relevant regulatory framework and marketing considerations;
- 3
Critically evaluate methodologies and data from experiments in the context of the drug development process;
- 4
Obtain, present and interpret data from pharmacological experiments relevant to the area of drug development;
- 5
Source, integrate and critically evaluate the scientific literature to address an issue in the area of drug development and to communicate this orally, in written form or via a poster presentation;
- 6
Work both independently and as part of a team.
Workload and teaching
- Lectures24 hours
- Laboratories12 hours
- Workshops24 hours
- Teaching approachCase-based teaching
- Teaching approachOnline learning
- Teaching approachActive learning
- Teaching approachWork-integrated learning
- Teaching approachRole play
- Teaching approachPeer assisted learning
Two 1-hour lectures and three hours of laboratory or self-directed learning/ tutorial per week.
A case study focussed on drug development is used to contextualise the Unit content
Online activities will be used to help students consolidate and apply key concepts
This unit uses a student-centered, active learning approach which aims to encourage the build-up of knowledge and understanding that is required to achieve a deeper level of learning to facilitate efficient use of knowledge
Authentic learning activities will be undertaken to build knowledge and understanding of the drug development process within industry & academia
Students will assume the role of a research & development team within a pharmaceutical company to gain an indepth understanding and appreciation of the steps in the drug discovery process
Self- and peer-marking sessions will help students develop skills to critically evaluate their own and others' work as well as engaging them in the assessment process
Learning resources
Required resources
Rang HP, Dale MM, Ritter JM, Flower RJ & Henderson G. Rang & Dale’s Pharmacology 8th edn, Churchill Livingstone, 2016.
Recommended resources
Rang HP. Drug Discovery and Development: Technology in Transition 2nd edn. Churchill Livingstone, 2013.
Where it fits
PHA3042 is part of 1 area of study in the 2020 handbook.
Contacts
- Unit Coordinators
- Dr Mark Del Borgo
- Dr Eva Patak
- Chief Examiners
- Associate Professor Barbara Harper
Common questions
What are the prerequisites for PHA3042?
PHA3042 has no prerequisites, but enrolment rules apply.
What can I take after PHA3042?
PHA3042 is a prerequisite or corequisite for 1 unit, including BTH3960.
When is PHA3042 offered?
In 2020, PHA3042 runs in Semester 2 at Clayton.
Does PHA3042 have an exam?
Yes. The exam is worth 25% of the final mark, alongside 1 other task.
Which majors and minors include PHA3042?
PHA3042 is part of Pharmacology.